Apone SRL
The score of Apone shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +320 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apone's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Mar 2026
- Year ended 31 Dec 2024filed on 27 Feb 2025
- Year ended 31 Dec 2023filed on 04 Mar 2024
Apone's financial analysis
- Solvency16.8%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apone
Apone's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0805.241.045
- VAT number
- BE0805241045
- Peppol
- Registered · 0208:0805241045 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Aug 2023
- Registered office
- 2620 Hemiksem
- Latest accounts
- 2025 · filed on 18 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apone (SRL) has been based in Hemiksem since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 47,188 € and equity of 109,763 €; its revenue is not published. Its solvency stands at 16.8%, below the median of its sector (44.0%).
Companies similar to Apone
Companies in the same business, of comparable size and area, outside its group.
- VdC Invest Retail sale of pharmaceutical products Lierde · balance sheet 660,114 €
- Kesters Pharma Invest Retail sale of pharmaceutical products Houthalen-Helchteren · balance sheet 469,134 €
- Apkpharma Retail sale of pharmaceutical products Manage · balance sheet €1.05m
- geroFarma Retail sale of pharmaceutical products Kortrijk · balance sheet €1.05m
- Apotheek De Boeck Retail sale of pharmaceutical products Lierde · balance sheet €1.30m
- Duchi-Naert Retail sale of pharmaceutical products Harelbeke · balance sheet €1.52m
- Pharmakes Retail sale of pharmaceutical products Ypres · balance sheet €1.57m
- Cardoen Pharma Retail sale of pharmaceutical products Wingene · balance sheet €1.79m
Frequently asked questions about Apone
What is the revenue of Apone?
Apone files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apone?
In Belgium, the VAT number is the company number prefixed with BE: BE0805241045 for Apone, if the company is VAT-registered. Its company number (CBE) is 0805.241.045.
Where is the registered office of Apone?
According to the CBE register, the registered office of Apone is in 2620 Hemiksem.
What is the equity of Apone?
At the close of the 2025 financial year, the equity of Apone amounts to 109,763 €, a solvency of 16.8% of total assets.
Who manages Apone?
The register lists 2 active mandates at Apone. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apone
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →